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Abstract
Glutamate excitotoxicity, metabolic rate and inflammatory response have been associated to the deleterious effects of
temperature during the acute phase of stroke. So far, the association of temperature with these mechanisms has been
studied individually. However, the simultaneous study of the influence of temperature on these mechanisms is necessary to
clarify their contributions to temperature-mediated ischemic damage. We used non-invasive Magnetic Resonance
Spectroscopy to simultaneously measure temperature, glutamate excitotoxicity and metabolic rate in the brain in animal
models of ischemia. The immune response to ischemia was measured through molecular serum markers in peripheral
blood. We submitted groups of animals to different experimental conditions (hypothermia at 33uC, normothermia at 37uC
and hyperthermia at 39uC), and combined these conditions with pharmacological modulation of glutamate levels in the
brain through systemic injections of glutamate and oxaloacetate. We show that pharmacological modulation of glutamate
levels can neutralize the deleterious effects of hyperthermia and the beneficial effects of hypothermia, however the analysis
of the inflammatory response and metabolic rate, demonstrated that their effects on ischemic damage are less critical than
glutamate excitotoxity. We conclude that glutamate excitotoxicity is the key molecular mechanism which is influenced by
body temperature during the acute phase of brain stroke.
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Introduction
Stroke is a leading cause of mortality and morbidity in
developed countries, with increasing incidence due to the
progressive aging of their population. Pharmacological or
mechanical reperfusion therapy is the most effective treatment
during the acute phase of ischemic stroke, and it is associated with
good outcome in 50–70% of cases. However, these treatments are
only applicable to less than 10% of patients, due to severe
restrictions that include a short therapeutic window [1]. The
management of body temperature is becoming one the most
promising neuroprotective strategies during the acute phase of
stroke, for those cases in which reperfusion is not recommended
[2,3]. Understanding the underlying mechanisms by which
temperature affects the progression of ischemic tissue may lead
to advances for the treatment of stroke.
Earlier studies have associated temperature effects with gluta-
mate excitotoxicity and with alterations of the metabolic rate and
the inflammatory response, as these processes were exacerbated by
hyperthermia and reduced under hypothermic conditions [3]. So
far, such associations have been studied in isolation, and we are
not aware of studies in which the relevance of these three
mechanisms was evaluated together.
Previously published studies [4,5] prompted us to postulate that
the most critical mechanism that affects temperature-related
damage is glutamate excitotoxicity, compared with metabolic rate
and inflammatory response. To test this hypothesis, we combined
a pharmacological approach with temperature changes to alter
brain glutamate levels. Our pharmacological approach is based on
the fact that there is a direct correlation between glutamate levels
in blood and in brain extracellular medium [6]. Thus, the increase
of glutamate concentration in blood by systemic injection of this
substance it is reflected in an increase of extracellular glutamate
levels on the ischemic brain, exacerbating its excitotoxic effects.
Conversely, reduction of blood glutamate concentrations by
treatment with oxaloacetate, a co-substrate of the blood-borne
enzyme glutamate oxaloacetate transaminase (GOT), leads to a
reduction of extracellular glutamate in the brain, with a
subsequent reduction of its excitotoxic effects (see [7] for review).
PLOS ONE | www.plosone.org 1 August 2012 | Volume 7 | Issue 8 | e44191In the present work we have used non invasive techniques, such
as Magnetic Resonance Spectroscopy (MRS) and Imaging (MRI),
to study an animal model of ischemia under hypo-, normo- and
hyperthermic conditions; we show that it is possible to modulate
the deleterious effects of hyperthermia and the neuroprotective
effects of hypothermia by pharmacologically influencing the
excitotoxic effect of glutamate. The analysis of the effects of
temperature on metabolic rate, inflammatory response and
glutamate excitotoxicity indicates that the latter mechanism is
the one that presents the strongest association with temperature.
Materials and Methods
Animals
Experimental protocols were approved by the local Animal
Care Committee according to the Spanish and European Union
legislation (86/609/CEE, 2003/65/CE, and RD 1201/2005).
Male Sprague-Dawley rats (Harlan Laboratories, Udine, Italy)
with a weight ranging from 300 to 330 g were used. Rats were
provided with water and food ad libitum. Anesthesia was induced
by inhalation of 5% sevoflurane in a nitrous oxide/oxygen mixture
(70/30). Glucose levels remained at normal levels prior to surgery
(180 to 220 mg/dl).
Surgical Procedures
Transient (90 min) focal ischemia was induced by intraluminal
occlusion of the middle cerebral artery (MCA), as described
elsewhere [8]. A laser-Doppler flow probe (tip diameter 1 mm)
attached to a flow meter (PeriFlux 5000; PerimedAB, Stockholm,
Sweden) was placed on the thinned skull over the MCA territory
(4 mm lateral to Bregma) to continuously record the relative
cerebral blood flow (CBF) during the experiment. Only animals
with a reduction of CBF higher than 60%, and with effective
reperfusion after retrieving the filament, were included in the
study.
Experimental Groups
Two sets of experiments were designed:
1) Effect of temperature on glutamate levels on healthy rats -
Three different groups of healthy animals were subjected to
different body temperatures, hypothermia (3361uC, n=7),
normothermia (3761uC, n=7) and hyperthermia (3961uC,
n=7), to study the effects of temperature on blood glutamate
concentration. Body temperature was maintained by using a
feedback-controlled heating pad. Blood samples (200 mL)
were withdrawn under basal conditions (normothermia) and
after achieving the selected target temperatures.
2) Effect of temperature on ischemic rats - Five groups were
used to study the effect of temperature and blood glutamate
concentrations: group A: ischemic animals subjected to
hypothermia (n=8); group B: ischemic animals subjected to
normothermia (n=7); group C: ischemic animals subjected to
hyperthermia (n=7); group D: ischemic animals subjected to
hypothermia and treated with 7.27 g/kg of glutamate (n=8);
group E: ischemic animals subjected to hyperthermia and
treated with 35 mg/kg of oxaloacetate (n=8). Glutamate and
oxaloacetate were administered before the beginning of
MCAo surgery. In each group, temperature (33uC, 37uCo r
39uC 61) was maintained from the beginning of the surgery
(duration of surgery: 30–40 min), during MCA occlusion
(90 min) and up to 150 min after reperfusion (duration of
MR studies). For all groups, concentrations of blood
glutamate and IL-6 were determined at the beginning of
the experiment (basal values; before surgery and normother-
mia) and 90 min after occlusion of the MCA, just after
reperfusion. For all groups, brain temperature and relative
cerebral glutamate and lactate levels were determined by
MRS during MCA occlusion and up to 150 min after
reperfusion. To do so, animals were carefully taken from the
surgery table after occlusion of the MCA and placed in the
MRI system. An MR angiography was first performed to
confirm that the MCA remained occluded. After 90 min of
occlusion, animals were taken out of the MRI and the
filament was removed. Subsequently animals were placed
again in the MRI instrument and relative brain glutamate
and lactate levels were analyzed by MRS for a period of
150 min after reperfusion. Infarct volumes were measured in
all animals 90 min after the occlusion (by diffusion-weighted
images) and 7 days later (T2-weighted images).
Figure 1. Brain temperature in the ischemic and the contralat-
eral (healthy) brain hemispheres, as determined from Magnetic
Resonance measurements on ischemic animals with body
temperatures of 396C (top), 376C (middle) and 336C (bottom).
Statistical significances: *P,0.05.
doi:10.1371/journal.pone.0044191.g001
Temperature vs Glutamate in Acute Stroke
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Blood samples were collected from the tail vein, centrifuged at
3000 g for 15 minutes and immediately frozen and stored at
280uC. Serum levels of glutamate were determined by high
performance liquid chromatography (HPLC), as described else-
where [9].
Plasma IL-6 Analysis
Plasma levels of IL-6 were determined using an immunodiag-
nostic IMMULITE 1000 System (Diagnostic Products Corpora-
tion, California, USA). Levels of IL-6 were analyzed under basal
conditions (37uC, before surgery), and 90 min after occlusion of
the MCA, just after reperfusion.
Magnetic Resonance Imaging: Infarct Volume Analysis
MRI and MRS studies were conducted on a 9.4T horizontal
bore magnet (Bruker BioSpin, Ettligen, Germany) with 20 cm
wide actively shielded gradient coils (440 mT/m). Radio frequen-
cy transmission was achieved with a bird cage volume resonator;
signal was detected using a four elements surface coil positioned
over the head of the animals. Infarct sizes were assessed from MRI
images. Apparent diffusion coefficient (ADC) maps were acquired
before removing the filament from the animal (90 minutes after
Figure 2. MRI images and quantification of infarct volumes at 90 min (DWI MR images) and 7 days (density maps from T2-MRI
images) after the induction of cerebral ischemia in animals submitted to hypothermia (336C, n=8), normothermia (376C, n=7),
hyperthermia (396C, n=7), hypothermia and 7,27 g/kg of glutamate (Glu) (n=8) and hyperthermia (n=8) and 35 mg/Kg
oxaloacetate (OAA). ). Color-coded density maps were generated from T2 MR images from one brain slice for each animal (Located at Bregma
+0.7 mm). The color code indicates the percentage of animals within a group that shows a lesion in each particular pixel. The grey image used as
background is the result of the mean value of all co-registered images per group. Infarct volumes (% of hemispheric volume affected by lesion) are
shown as mean 6 S.D. Statistical significances: ***P,0.001, **P,0.01 compared to normothermic animals. ##P,0.01 compared to non-treated
hypothermic animals, 11P,0.01 compared to non-treated hyperthermic animals.
doi:10.1371/journal.pone.0044191.g002
Temperature vs Glutamate in Acute Stroke
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with the following acquisition parameters: field-of-view
19.2619.2 mm
2, image matrix 1286128 (in-plane resolution
0.15 mm/pixel), 14 consecutive slices of 1 mm thickness, repeti-
tion time =4 s, echo time =30 ms, and diffusion b values: 0, 100,
300, 600, 800, 1000, and 1400 s/mm
2. T2-weighted images were
acquired 7 days after the induction of ischemia using a multi-slice
multi-spin-echo sequence with the following acquisition parame-
ters: field-of-view 19.2619.2 mm
2, image matrix 1926192 (iso-
tropic in-plane resolution of 0.1 mm/pixel), 14 consecutive slices
of 1 mm thickness, repetition time =3 s, and 16 echoes with echo
time =9 ms.
In vivo Magnetic Resonance Spectroscopy: Glutamate
and Lactate Analysis
MR spectra were acquired as described elsewhere [10,11].
Localized spectroscopic data were collected from a 36363m m
3
voxel (27 mL) covering part of the cortex and striatum of the
stroke-affected hemisphere (mostly filled by ischemic tissue). A
second voxel was selected at the contralateral hemisphere
(healthy tissue), for reference. Local shimming was performed by
manual adjustment of first- and second-order shim coils, using a
proton stimulated-echo acquisition mode (STEAM) pulse
sequence. Field homogeneity resulted in typical signal line
widths of 10–20 Hz for the water peak. Water signal was
suppressed using a VAPOR scheme (bandwidth =350 Hz).
In vivo 1H spectra of the rat brain were acquired by using a
STEAM sequence with echo time TE=3 ms, mixing time
TM=5 ms, repetition time TR=2.5 s, N=176 averages. Outer
volume suppression was applied. Spectra were processed using
TOPSPIN 2.0 (Bruker Biospin, Ettlingen, Germany) and M-
Nova (MestreLab Research, Santiago de Compostela, Spain).
For the quantitative analysis, glutamate and lactate signals were
normalized with the creatine peak areas, used as internal
reference, for each single spectrum.
Brain Temperature Estimation
Mapping of brain temperature by MR has been previously
validated [12,13]. Cerebral temperature for each voxel was
calculated based on the fact that temperature-dependent changes
in hydrogen bonding linearly affect the chemical shift of water
(dH2O), with a slope of 0.01 ppm per uC [14], whilst the chemical
shift of N-acetyl aspartate (dNAA) is basically independent of
temperature.
We validated the MRS thermometry technique in our 9.4 T
system with a 1 mM solution of N-acetyl aspartate (NAA)
subjected at a range of temperatures from 30 to 40uC.
Statistical analysis showed a Pearson’s Coefficient=0.965
(p,0.0001) between temperature and the difference of chemical
shifts of water and N-acetyl aspartate (D=dH2O2dNAA). To
determine the relationship between chemical shift differences
and brain temperature, we selected two groups of healthy
animals (n=9 each), inserting a temperature micro-sensor in the
brain of the animals of one of the groups, and measuring the
temperature of the brain inside the magnet, while body
temperature was subjected to a range of temperatures from
30 to 39uC. A second group of animals was placed in the MR
and subjected to the same range of body temperatures,
measuring the chemical shifts of NAA and water. Pearsons
correlation coefficients were 0.943 (p,0.0001) and 0.893
Figure 3. Pseudocolor T2 weighted MR images of a representative brain of each group. Images include 7 consecutive 1-mm thick coronal
slices, showing the extent of the ischemic damage throughout the whole brain (position of each slice compared to Bregma, to Paxinos and Watson
[45], is presented at the bottom).
doi:10.1371/journal.pone.0044191.g003
Temperature vs Glutamate in Acute Stroke
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derive the following equation to estimate brain temperature
from MRS measurements: cerebral temperature
(Ct)=237.2792(75.2896D), where D reflects the difference of
values of the chemical shift of NAA and water (in PPM).
Image Analysis
All images were processed with ImageJ (Rasband WS, ImageJ,
US National Institutes of Health, Bethesda, MD, USA, http://rsb.
info.nih.gov/ij/, 1997–2009). Infarct volumes were determined
from quantitative ADC (apparent diffusion coefficient) and T2
maps by a researcher blinded to animal treatment.
Statistical Analysis
Results are expressed as percentages for categorical variables
and as mean (6 standard deviation) or median (quartiles) for
continuous variables, depending on the normality of the data
distribution. Proportions were compared using the x
2 test. The
Student’s t-test or the Mann–Whitney test were used to compare
continuous variables between groups. Spearman or Pearson
analyses were used for bivariate correlations. ANOVA test was
used to compare multiple quantitative variables.
Results
Brain Temperature in the Ischemic Brain
Brain temperature was determined in ischemic animals by non-
invasive MRS measurements, under hypo-, normo- and hyper-
thermic conditions (Figure 1). Reducing body temperature to 33uC
was paralleled by a reduction in brain temperature, with no
significant differences between ipsilesional and contralateral brain
hemispheres (p=0.125). In hyperthermic animals, an increase of
body temperature to 39uC was reflected in an increase of brain
temperature. At variance with hypothermic animals, under
normo- and hyperthermia conditions significant temperature
differences (p=0.0001 and p=0.007, respectively) were observed
between the ipsilesional and the contralateral brain hemispheres.
In general, changes in body temperature were associated with
changes in the temperature of the ischemic brain, with higher
temperatures (differences up to 0.5uC) observed for the ipsilesional
brain hemisphere compared to the contralateral (healthy) side.
Effects of Body Temperature on the Ischemic Damage
Infarct volumes were measured in ischemic animals submitted
to different experimental conditions at 90 min (diffusion-weighted
images) and 7 days (T2-weighted images) from the induction of
Figure 4. Blood glutamate levels (mM) in healthy and in ischemic animals submitted to hypothermia (336C, n=8), normothermia
(376C, n=7), hyperthermia (396C, n=7), hypothermia plus 7.27 g/Kg glutamate (Glu) (n=8) and hyperthermia plus 35 mg/Kg
oxaloacetate (OAA) (n=8) (A). Basal glutamate levels were determined in all groups under normothermic conditions. Ischemic levels were
determined 90 min after occlusion. Levels are shown as mean6S.D. Statistical significances: **P,0.01, *P,0.05 compared to normothermic animals.
Brain glutamate levels (corrected as the ratio between glutamate and creatine MRS peak) for the same groups of animals (B). Glutamate levels were
determined during the occlusion (90 min) and after reperfusion (180 min). Levels are shown as mean6S.D. ***P,0.001, *P,0.05 compared to
normothermic animals.
doi:10.1371/journal.pone.0044191.g004
Temperature vs Glutamate in Acute Stroke
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hemispheric volume affected by ischemia) were not different for all
the studied groups at 90 min from the occlusion of the MCA
(p=0.995).
Under hypothermic conditions, infarct volumes were reduced at
7 days after occlusion (V=15610.8% of hemispheric volume)
compared to their initial value at 90 min (V=3264.0% of
hemispheric volume) (p,0.0001). Such reduction in lesion
volumes was not detected for normothermic animals
(V=3263.4% at 90 min vs. 27611.9% at day 7) (p=0.079).
Conversely, infarct volumes were increased in animals subjected to
hyperthermia (V=3363.2% at 90 min and V=4768.0% at day
7) (p,0.0001). Infarct volumes at 7 days were significantly smaller
for hypothermic animals (p=0.003), and larger for hyperthermic
animals (p,0.0001), with compared to normothermic animals
(Figure 2).
The reduction in infarct volumes induced by hypothermia was
not seen in animals pretreated with glutamate, which showed a
lesion volume of V=3667.4% at day 7 compared to an initial
value of V=3263.2% at 90 min (p=0.308). Similarly, the
increase in lesion volumes observed for hyperthermic animals
was not seen after treatment with oxaloacetate (V=24611.9% at
day 7, vs V=3267.4% at 90 min) (p=0.065).
The extent of ischemic damage along the whole brain for the
different study groups is shown in Figure 3. Hyperthermia, as well
the injection of glutamate, extended the damage toward the caudal
sections of the brain. Conversely, hyperthermia and treatment
with oxaloacetate reduced the intensity of the damage on the
tissue.
Effect of Temperature on Blood and Brain Levels of
Glutamate under Ischemia
Under normothermic conditions (Figure 4A), 90 minutes of
ischemia induced an increase in blood glutamate levels from the
basal value of [glutamate]basal =2376111.9 mM to [glutama-
te]90 min (37uC)=3806167.4 mM, (p=0.018). Such difference was
smaller under hypothermic conditions ([glutamate]basal
=229697.9 mM vs [glutamate]90min (33uC)=278688.1 mM,
p=0.028), and larger under hyperthermic conditions ([glutama-
te]basal=251675.1 mM vs [glutamate]90 min
(39uC)=5306233.1 mM, p=0.016). Systemic treatment with
7.27 g/kg glutamate in hypothermic animals increased blood
glutamate levels during occlusion ([glutamate]90 min (33uC+gluta-
mate)=411.16302.1 mM). These values were similar to those
obtained for normothermic animals (p=0.157). In hyperthermic
animals, oxaloacetate treatment (35 mg/kg) reduced blood gluta-
mate levels, ([glutamate]90 min (39uC+oxaloaceta-
te)=376.66104.8 mM) to levels seen in normothermic animals
(p=0.159) (Figure 4A). Basal levels, measured in normothermic
conditions and before any treatment, were not different among all
studied groups (p=0.950). Body temperature did not affect blood
glutamate levels in healthy rats (p=0.175) (Figure 4A).
In the ischemic brain, hypothermia caused a significant
reduction of brain glutamate levels during the occlusion (Glu/
Cr-PCr)OCL (33uC)=1.960.5 and reperfusion (Glu/Cr-PCr)REP
(33uC)=0.860.4, compared with normothermic animals (Glu/
Cr-PCr)OCL (37uC)=2.661.0 and Glu/Cr-PCr)REP
(37uC)=1.660.8 (p,0.0001 and p,0.0001 respectively)
(Figure 4B). Conversely, hyperthermia induced a significant
increase in glutamate levels during occlusion Glu/Cr-PCr)OCL
(39uC)=3.261.6) and reperfusion (Glu/Cr-PCr)REP
(39uC)=2.461.3, compared to normothermic animals (p=0.023
and p=0.029 respectively) (Figure 4B). The effect of hypothermia
and hyperthermia on brain glutamate was prevented when
animals were systemically treated with glutamate or oxaloacetate,
respectively. Systemic treatment with 7.27 g/kg glutamate in
hypothermic animals increased brain glutamate levels during
occlusion (Glu/Cr-PCr)OCL (33uC+GLU)=2.560.6, and reper-
fusion (Glu/Cr-PCr)REP (33uC+GLU)=1.460.4. These values
were similar to those obtained for normothermic animals
(p=0.427 and p=0.109, respectively). In hyperthermic animals,
oxaloacetate treatment (35 mg/kg) reduced brain glutamate levels,
Figure 5. Blood Interleukin-6 levels (in pg/mL) in animals
submitted to hypothermia (336C, n=8), normothermia (376C,
n=7), hyperthermia (396C, n=7), hypothermia plus 7.27 g/Kg
glutamate (Glu) (n=8) and hyperthermia plus 35 mg/Kg
oxaloacetate (OAA) (n=8) (A). Lactate levels during occlusion
period (expressed as the ration glutamate/creatine-phosphocreatine
peak areas on MRS spectra) on the ischemic brain of the same group of
animals (B).
doi:10.1371/journal.pone.0044191.g005
Temperature vs Glutamate in Acute Stroke
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(39uC+OAA)=1.861.1, to levels seen in normothermic animals
(p=0.079 and p=0.107, respectively) (Figure 4B). Glutamate
levels in contralateral region (non ischemic region) were used as
control region. Both ischemia, temperature, glutamate or oxalo-
acetate treatments did not modified glutamate levels in this region.
Effect of Temperature on Acute Inflammatory Response
under Ischemia
Levels of Interleukin 6 (IL-6) were determined under basal
conditions and 90 min after induction of ischemia, under the five
study conditions (Figure 5A). No significant differences were
observed for basal concentrations (global mean =219631.15 pg/
mL, p=0.640). This value remained at the same levels after
90 minutes of ischemia for normothermic animals
(215630.23 pg/mL) (p=0.463), while it was reduced under
hypothermic conditions (99627.90 pg/mL) (p,0.0001), and
increased under hyperthermia (304651.03 pg/mL) (p,0.0001).
Pharmacological modulation of systemic levels of glutamate did
not affect to IL-6 levels. Hypothermic animals treated with
glutamate (109620,62 pg/mL) or hyperthermic animals treated
with oxaloacetate (286620.11 pg/mL) showed values similar to
those observed at the same temperatures, without pharmacological
treatment (p=0.107 and p=0.377, respectively) (Figure 5A).
Effect of Temperature on Brain Metabolic Rate under
Ischemia
Brain levels of lactate, as determined by MRS were found to be
higher during (following) occlusion and were not significantly
different (p=0.074) among all studied groups; LAc/Cr-PCr ratio
=2.4560.62 (33uC), 2.7360.88 (37uC), 2.4860.85 (39uC),
2.7860.06 (33uC+Glu) and 2.2860.65 (39uC+OAA) (Figure 5B).
Discussion
The MRI data presented in this study show that animals
submitted to hyperthermia present with larger lesion volumes at
day 7, compared to normothermic animals and hypothermic
animals, which show the smallest lesion volumes (Figure 2 and 3).
The fact that hyperthermia exacerbates ischemic damage while
hypothermia offers a neuroprotective effect during acute ischemia
is not new, and the role of temperature in cerebral ischemia has
been extensively discussed in the literature (see [3] and [15] for
recent reviews on this topic).
The novelty of this work relies on the use of pharmacological
approaches to modulate glutamate levels on the brain, which has
enabled us to demonstrate the tight association existing between
temperature and glutamate excitotoxicity, and evaluate the
mechanisms of action underling the effects of temperature during
acute phase of stroke.
The successful combination of hypothermia with pharmacolog-
ical strategies, based on the reduction of glutamate excitotoxicity,
has been already proposed [16,17], but none of these works really
demonstrate an association between both mechanisms. Here we
have followed a different approach, as we modulated the brain
levels of glutamate by acting on systemic levels, in order to
evaluate by non-invasive means the role of glutamate release on
the effects of temperature. Our findings indicate that systemic
administration of glutamate leads to an increase of brain glutamate
levels in the infarcted regions (though not in the contralateral
region), and reverses the neuroprotective effects of hypothermia.
Moreover, systemic administration of oxaloacetate reduces brain
levels of glutamate and prevents the deleterious effects of
hyperthermia, reducing lesion volumes at day 7 to values observed
for untreated normothermic animals (Figure 2). Therefore, our
data suggest that temperature effects during acute ischemia are
strongly associated to glutamate excitotoxicity.
It is well known that during cerebral ischemia, glutamate
excitotoxicity occurs when a large amount of glutamate is released
from brain tissue into the extracellular space, as documented by
in vitro studies [18], in vivo animal studies [19,20], and in ischemic
patients [5,21,22]. However the mechanism throughout temper-
ature modifies the brain glutamate release is not completely
understood. Cerebral ischemia results from a reduction of
complete loss of cerebral blood flow, followed by a depletion of
ATP and occurrence of anoxic depolarization and spreading
depression. These molecular events lead to a large increase of
glutamate from intracellular space to extracellular space; which
stimulates NMDA receptors and leads to increased intracellular
calcium levels [23]. Based on this sequence of molecular process, it
is tempting to speculate that the effect of temperature on
glutamate release is mediated through its effects on ATP depletion
and the occurrence of anoxic depolarization. However, in our
point of view, temperature induces a pleiotropic effect; there is not
a unique molecular mechanism able to explain the effect of
temperature on glutamate release.
In agreement with previous clinical studies [5,22], we have
observed that hypothermia induces a reduction of blood glutamate
levels with respect to normothermic animals, and hyperthermia
induces the opposite effect; a pattern similar to the one observed in
brain glutamate levels. The most acceptable explanation of this
effect is that ischemia causes a permeability and/or disruption of
the brain blood barrier (BBB) in the infarct region [24,25,26],
allowing the diffusion of glutamate from brain to blood. However
it is possible that there could be another mechanism by which
body temperature affects blood glutamate homeostasis and its
levels. Based on this idea and since alterations of blood glutamate
can influence brain glutamate levels [6,27,28,29,30,31], we
wanted to prove the influence of temperature on blood glutamate.
With this purpose, healthy animals were submitted to hypo-,
normo- and hyperthermia. We observed no difference in blood
glutamate levels among the three groups. Thus, our data suggest
that temperature directly affects brain levels of glutamate rather
than glutamate homeostasis in the body, supporting the idea that
blood glutamate concentration is one of the best markers of
neuronal damage in stroke patients [32].
To test to what extent temperature has an effect on the
metabolic rate under ischemia; we measured brain levels of lactate
by MR spectroscopy. Lactate is a marker of anaerobic metabolism
and is thought to be correlated with the level of oxygen deprivation
and ischemia [33,34,35]. We hypothesized that lactate levels
should be temperature dependent on the ischemic brain if
temperature affects metabolic rate. Our study shows no association
between lactate levels and brain temperature or infarct volumes
for any of the studied groups.
Other authors have related elevated temperatures with higher
metabolic rates [36,37]. However, a comparison of patterns of
lactate concentration and temperature elevation in different
regions of the ischemic brain showed that there was no causal
association between both parameters [13]. The most plausible
explanation for the correlations between metabolic rate and
temperature relies on the fact that brain temperature is mainly
elevated in the ischemic penumbra, an area of elevated metabolic
rate [12]. The higher temperature of the ischemic penumbra may
be the consequence of alterations of cerebral blood flow and an
inflammatory response, which takes place locally at this ischemic
region during early stages of ischemic stroke. Reduced blood flow
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ischemic lesion, where cells may still be metabolically active.
Similarly, the local inflammation response is linked to the
elevation of tissue temperature, which appears minutes after
induction of ischemia [2,3]. It is well established that inflammation
plays a key role in the physiopathology of ischemic stroke [38,39].
The existence of an inflammatory cascade with pyretic activity
that is associated with the activation and infiltration of microglia,
macrophages and leukocytes (especially at the peri-infarct zone)
has been demonstrated in animal models [40]. The beneficial
effects of hypothermia have been related to the inhibition of the
cellular response (accumulation of inflammatory cells in the peri-
infarct zone) and of the humoral response (release of pro-
inflammatory cytokines) to stroke [41].
Blood levels of interleukin 6 (IL-6), a known marker of early
inflammation [41,42,43], show that the immune response is
inhibited by hypothermia and exacerbated by hyperthermia.
However, the fact that in our study levels of IL-6 were not affected
by the pharmacological modulation of glutamate levels, as was
temperature, may indicate a non causal relationship between
temperature and the inflammatory response. Such relationship
may not be the same in later phases of stroke. We have recently
demonstrated in a clinical study that the therapeutic window for
hypothermia persists for at least 48 hours, and that it is associated
with inflammatory mechanisms [2]. Experimental studies have
also demonstrated that hypothermia induces neuroprotective
effects even when this treatment is delayed by up to 6 h
[2,3,44]. It is the possible that the inflammatory response may
be mainly associated with the neuroprotective effect of hypother-
mia in later stages of ischemia.
In conclusion, the present study shows that, among the different
mechanisms of damage during the acute phase of stroke,
excitotoxicity of glutamate is the most closely related to the effects
of temperature during this stage. Causal relationships between
temperature and other mechanisms of damage, like the presence
of increased metabolic rates or inflammatory response, may
become more relevant during the subacute or chronic phases of
the disease. Based on our findings, we postulate that neuropro-
tective strategies inhibiting glutamate excitotoxicity may enhance
the beneficial effects of hypothermia during the acute phase of
stroke.
Author Contributions
Conceived and designed the experiments: FC JC PRC. Performed the
experiments: MPM JA D. Barrel D. Brea. Analyzed the data: MB JC.
Wrote the paper: FC AA CW JC PRC.
References
1. Tomsick TA, Khatri P, Jovin T, Demaerschalk B, Malisch T, et al. (2010)
Equipoise among recanalization strategies. Neurology 74: 1069–1076.
2. Blanco M, Campos F, Rodriguez-Yanez M, Arias S, Fernandez-Ferro J, et al.
(2012) Neuroprotection or increased brain damage mediated by temperature in
stroke is time dependent. PLoS One 7: e30700.
3. Campos F, Blanco M, Barral D, Agulla J, Ramos-Cabrer P, et al. (2012)
Influence of temperature on ischemic brain: basic and clinical principles.
Neurochem Int 60: 495–505.
4. Castellanos M, Sobrino T, Pedraza S, Moldes O, Pumar JM, et al. (2008) High
plasma glutamate concentrations are associated with infarct growth in acute
ischemic stroke. Neurology 71: 1862–1868.
5. Castillo J (1999) Deteriorating stroke: diagnostic criteria, predictors, mechanisms
and treatment. Cerebrovasc Dis 9 Suppl 3: 1–8.
6. Teichberg VI, Cohen-Kashi-Malina K, Cooper I, Zlotnik A (2009) Homeostasis
of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess
glutamate is produced by blood glutamate scavenging and offers protection from
neuropathologies. Neuroscience 158: 301–308.
7. Campos F, Sobrino T, Ramos-Cabrer P, Castillo J (2012) Oxaloacetate: A novel
neuroprotective for acute ischemic stroke. Int J Biochem Cell Biol 44: 262–265.
8. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle
cerebral artery occlusion without craniectomy in rats. Stroke 20: 84–91.
9. White JA, Hart RJ, Fry JC (1986) An evaluation of the Waters Pico-Tag system
for the amino-acid analysis of food materials. J Automat Chem 8: 170–177.
10. Higuchi T, Graham SH, Fernandez EJ, Rooney WD, Gaspary HL, et al. (1997)
Effects of severe global ischemia on N-acetylaspartate and other metabolites in
the rat brain. Magn Reson Med 37: 851–857.
11. Tkac I, Starcuk Z, Choi IY, Gruetter R (1999) In vivo 1H NMR spectroscopy of
rat brain at 1 ms echo time. Magn Reson Med 41: 649–656.
12. Karaszewski B, Wardlaw JM, Marshall I, Cvoro V, Wartolowska K, et al. (2006)
Measurement of brain temperature with magnetic resonance spectroscopy in
acute ischemic stroke. Ann Neurol 60: 438–446.
13. Karaszewski B, Wardlaw JM, Marshall I, Cvoro V, Wartolowska K, et al. (2009)
Early brain temperature elevation and anaerobic metabolism in human acute
ischaemic stroke. Brain 132: 955–964.
14. Germain D, Chevallier P, Laurent A, Saint-Jalmes H (2001) MR monitoring of
tumour thermal therapy. MAGMA 13: 47–59.
15. Yenari MA, Han HS (2012) Neuroprotective mechanisms of hypothermia in
brain ischaemia. Nat Rev Neurosci 13: 267–278.
16. Zausinger S, Westermaier T, Plesnila N, Steiger HJ, Schmid-Elsaesser R (2003)
Neuroprotection in transient focal cerebral ischemia by combination drug
therapy and mild hypothermia: comparison with customary therapeutic
regimen. Stroke 34: 1526–1532.
17. Zhu H, Meloni BP, Bojarski C, Knuckey MW, Knuckey NW (2005) Post-
ischemic modest hypothermia (35 degrees C) combined with intravenous
magnesium is more effective at reducing CA1 neuronal death than either
treatment used alone following global cerebral ischemia in rats. Exp Neurol 193:
361–368.
18. Antonelli T, Tomasini MC, Fournier J, Mazza R, Tanganelli S, et al. (2008)
Neurotensin receptor involvement in the rise of extracellular glutamate levels
and apoptotic nerve cell death in primary cortical cultures after oxygen and
glucose deprivation. Cereb Cortex 18: 1748–1757.
19. Berger R, Jensen A, Hossmann KA, Paschen W (1998) Effect of mild
hypothermia during and after transient in vitro ischemia on metabolic
disturbances in hippocampal slices at different stages of development. Brain
Res Dev Brain Res 105: 67–77.
20. Winfree CJ, Baker CJ, Connolly ES, Fiore AJ, Solomon RA (1996) Mild
hypothermia reduces penumbral glutamate levels in the rat permanent focal
cerebral ischemia model. Neurosurgery 38: 1216–1222.
21. Castillo J, Davalos A, Marrugat J, Noya M (1998) Timing for fever-related brain
damage in acute ischemic stroke. Stroke 29: 2455–2460.
22. Castillo J, Davalos A, Noya M (1997) Progression of ischaemic stroke and
excitotoxic aminoacids. Lancet 349: 79–83.
23. Zhao H, Steinberg GK, Sapolsky RM (2007) General versus specific actions of
mild-moderate hypothermia in attenuating cerebral ischemic damage. J Cereb
Blood Flow Metab 27: 1879–1894.
24. Abbruscato TJ, Davis TP (1999) Combination of hypoxia/aglycemia compro-
mises in vitro blood-brain barrier integrity. J Pharmacol Exp Ther 289: 668–
675.
25. Fischer S, Clauss M, Wiesnet M, Renz D, Schaper W, et al. (1999) Hypoxia
induces permeability in brain microvessel endothelial cells via VEGF and NO.
Am J Physiol 276: 812–820.
26. Mark KS, Davis TP (2002) Cerebral microvascular changes in permeability and
tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ
Physiol 282: 1485–1494.
27. Campos F, Rodriguez-Yanez M, Castellanos M, Arias S, Perez-Mato M, et al.
(2011) Blood levels of glutamate oxaloacetate transaminase are more strongly
associated with good outcome in acute ischaemic stroke than glutamate pyruvate
transaminase levels. Clin Sci (Lond) 121: 11–17.
28. Campos F, Sobrino T, Ramos-Cabrer P, Castellanos M, Blanco M, et al. (2011)
High blood glutamate oxaloacetate transaminase levels are associated with good
functional outcome in acute ischemic stroke. J Cereb Blood Flow Metab 31:
1387–1393.
29. Gottlieb M, Wang Y, Teichberg VI (2003) Blood-mediated scavenging of
cerebrospinal fluid glutamate. J Neurochem 87: 119–126.
30. Zlotnik A, Gurevich B, Artru AA, Gruenbaum SE, Dubilet M, et al. (2010) The
effect of hyperthermia on blood glutamate levels. Anesth Analg 111: 1497–1504.
31. Zlotnik A, Sinelnikov I, Gruenbaum BF, Gruenbaum SE, Dubilet M, et al.
(2012) Effect of glutamate and blood glutamate scavengers oxaloacetate and
pyruvate on neurological outcome and pathohistology of the hippocampus after
traumatic brain injury in rats. Anesthesiology 116: 73–83.
32. Castellanos M, Serena J (2007) Applicability of biomarkers in ischemic stroke.
Cerebrovasc Dis 24 Suppl 1: 7–15.
33. Fillenz M (2005) The role of lactate in brain metabolism. Neurochem Int 47:
413–417.
34. Schurr A (2002) Lactate, glucose and energy metabolism in the ischemic brain
(Review). Int J Mol Med 10: 131–136.
35. Stillman AE, Latchaw RE (1993) On cerebral lactate production and blood flow
in acute stroke. J Magn Reson Imaging 3: 682–683.
Temperature vs Glutamate in Acute Stroke
PLOS ONE | www.plosone.org 8 August 2012 | Volume 7 | Issue 8 | e4419136. Clark DL, Penner M, Orellana-Jordan IM, Colbourne F (2008) Comparison of
12, 24 and 48 h of systemic hypothermia on outcome after permanent focal
ischemia in rat. Exp Neurol 212: 386–392.
37. Lo EH, Steinberg GK (1992) Effects of hypothermia on evoked potentials,
magnetic resonance imaging, and blood flow in focal ischemia in rabbits. Stroke
23: 889–893.
38. Da ´valos A, Castillo J, Pumar JM, Noya M (1997) Body temperature and
fibrinogen are related to early neurological deterioration in acute ischemic
stroke. Cerebrovasc Dis 7: 64–69.
39. Rodriguez-Yanez M, Castillo J (2008) Role of inflammatory markers in brain
ischemia. Curr Opin Neurol 21: 353–357.
40. Zaremba J (2004) Hyperthermia in ischemic stroke. Med Sci Monit 10: 148–
153.
41. Brea D, Sobrino T, Ramos-Cabrer P, Castillo J (2009) Inflammatory and
neuroimmunomodulatory changes in acute cerebral ischemia. Cerebrovasc Dis
27 Suppl 1: 48–64.
42. Brea D, Blanco M, Sobrino T, Ramos-Cabrer P, Castillo J (2011) The levels of
expression of toll-like receptors 2 and 4 in neutrophils are associated with the
prognosis of ischaemic stroke patients. Rev Neurol 52: 12–19.
43. Brea D, Sobrino T, Rodriguez-Yanez M, Ramos-Cabrer P, Agulla J, et al.
(2011) Toll-like receptors 7 and 8 expression is associated with poor outcome
and greater inflammatory response in acute ischemic stroke. Clin Immunol 139:
193–198.
44. van der Worp HB, Sena ES, Donnan GA, Howells DW, Macleod MR (2007)
Hypothermia in animal models of acute ischaemic stroke: a systematic review
and meta-analysis. Brain 130: 3063–3074.
45. Paxinos G, Watson C (2008) The rat brain in stereotaxic coordinates: Elsevier
Science & Technology.
Temperature vs Glutamate in Acute Stroke
PLOS ONE | www.plosone.org 9 August 2012 | Volume 7 | Issue 8 | e44191